Hainan Haiyao Co.Ltd(000566) : environmental, social and Governance Report of 2021

Environmental, social and Governance Report

CONTENTS

About Haiyao 1 green development 20 about this report 2 environmental management system 21 chairman's speech 3 promoting resource recycling 21 company overview 4 strengthening cleaner production 22 corporate governance 6 23 people-oriented

Governance structure 7

ESG management framework 9 protection of employees' rights and interests 24 stakeholder communication 10 promotion of employees' development 24 occupational health protection 24 reform and development 11 colorful employee activities 25 precise implementation and operation 12

Optimize the marketing mechanism 13 public welfare charity 26 innovation driven development 14 Rural Revitalization 27 quality and safety 16 enter the community 27 fight against the epidemic 28 strengthen quality management 17 evaluation of drugs after listing 17 safety production guarantee 18 customer service guarantee 19 sustainable supply chain management 19

2021 Environmental, Social and Governance Report

About Haiyao about us

ESG report description of the overview of this report

In this environmental, social and Governance Report (hereinafter referred to as the report), unless the context otherwise requires, the following words have the following meanings:

"ESG report") means Hainan Haiyao Co.Ltd(000566) issued:

Cloth's first ESG report mainly introduces the company's environment

Concept, practice and effectiveness of environmental, social and governance. CSRC refers to the China Securities Regulatory Commission

Content and scope Shenzhen stock exchange refers to Shenzhen Stock Exchange

Unless otherwise stated, the groups covered by this ESG Report

The scope of organization is Hainan Haiyao Co.Ltd(000566) and its subsidiaries. Xinxing Jihua Group Corporation Limited(601718) in this report refers to Xinxing Jihua Group Corporation Limited(601718) Co., Ltd

The time range covered is the same as the company's 2021 annual report

Consistent, from January 1 to December 3, 2021

11 days (hereinafter referred to as the "reporting period"). For the purpose of strengthening this pharmaceutical holding, it refers to Xinxing Jihua pharmaceutical Holding Co., Ltd

The comparability of the report, and some contents exceed the above requirements as needed

Describe the time range. Huatong industry refers to Hainan Huatong Industry Co., Ltd

Hainan Haiyao Co.Ltd(000566) . Company refers to Hainan Haiyao Co.Ltd(000566)

Preparation criteria

This report refers to Haikou Pharmaceutical Factory Co., Ltd. according to the Shanghai pharmaceutical factory issued by Shenzhen Stock Exchange

Municipal guidelines on corporate social responsibility and self-discipline supervision of listed companies

Prepared by the regulatory guidelines and the self regulatory guidelines for listed companies. Tiandi pharmaceutical refers to Chongqing Tiandi Pharmaceutical Co., Ltd

Preparation description Jiangsu Pujian refers to Jiangsu Pujian Pharmaceutical Co., Ltd

The information involved in this report comes from

The official documents and statistical reports of the company refer to Jiangsu hankuo biological Co., Ltd

The monetary amount is measured in RMB. company

The directors, supervisors and senior management ensure that the ESG report refers to Yancheng Kaiyuan Pharmaceutical Chemical Co., Ltd

The content of the report is true, accurate and complete, and there is no falsehood

False records, misleading statements or material omissions. Shanghai lishengte refers to the release form of Shanghai lishengte Medical Technology Co., Ltd. Lianqiao Yaodu refers to Hunan Lianqiao Yaodu Pharmaceutical Co., Ltd

This report is on the company's website

http://www.haiyao.com.cn. And tide GMP refers to the certification of drug production quality management practices

information net http://www.cn.info.com.cn. conduct

release. GSP refers to the certification of drug operation quality management practices

Strengthen management and control, increase efficiency and take responsibility for promoting development

Looking back on 2021, Hainan Haiyao Co.Ltd(000566) has gone through an extraordinary and challenging year.

The company actively responds

To meet the dual challenges brought by the reform of the national medical and health system and the covid-19 epidemic, we anchored the "one main and multiple" development strategy, strengthened production and operation control, and continued

Continue to optimize the layout of the industrial chain, steadily promote projects under construction, accelerate the progress of products under research, strengthen the construction of marketing resource channels, and effectively prevent heavy winds

Insurance, organize and carry out the activity of "learning party history, increasing confidence, improving performance and promoting development", and give full play to the leadership of the Party committee "taking direction, managing the overall situation and promoting implementation"

We have taken multiple measures to promote reform and development, firmly stabilized the basic situation of production and operation, and laid a solid foundation for accelerating the strategic development plan of the 14th five year plan

A good foundation has been laid.

In the new year, we will adhere to the main line of strengthening Party building, stabilizing operation and promoting development, adhere to using development methods to solve problems in development, and continue to

Accelerate development through adjustment and optimization. We will carry out the theme activity of "I am a party member, I am proud, I am a party member, I take responsibility, I do my duty" and

The special action of "operation compliance management year" has created an all-round entrepreneurial atmosphere of "taking responsibility as pride, focusing on development and striving for joy"

Risk management and control, promote compliance operation, and go all out to achieve Hainan Haiyao Co.Ltd(000566) set objectives and tasks.

In the new year, we will focus more on the main industry, give full play to our advantages, make up for our weaknesses and enhance the core competitiveness of enterprises. Focus on tamping the chemical medicine sector

Basics. Strengthen the industrial chain reinforcement and chain strengthening of the chemical medicine sector, adhere to the chess layout of intermediates, APIs and preparations, and give full play to the synergy of the industrial chain

And the competitive advantage of the industrial chain. Accelerate the expansion of traditional Chinese medicine products. Seize the development opportunity of national traditional Chinese medicine and focus on the development of Fengliao changweikang traditional Chinese medicine of the company

Varieties, carry out innovative research on the inheritance of traditional Chinese medicine, enrich the product group of traditional Chinese medicine, and lead the comprehensive revitalization of Hainan Li pharmaceutical industry. Strengthen R & D investment and scientific research management

Manage. According to the plan, we will accelerate the consistency evaluation and the clinical research of flufenidone capsules and pinegabine tablets, a class 1 new drug of two national chemical drugs.

Choose the opportunity to enter the field of biopharmaceutical. Combined with the company's resource endowment, carry out relevant demonstration work, timely build a biopharmaceutical platform, and strive to seek cross company cooperation

More and more development.

2022 has entered the April day of the world. The time for Hainan Haiyao Co.Ltd(000566) reform and development cannot wait. We must persevere even if the road ahead is difficult. We

Firmly believe that you can go wherever you want! Only by continuous struggle can we have a promising future. We will adhere to the thought of socialism with Chinese characteristics in the Xi Jinping new era

For guidance, enhance the guarantee ability of protecting the army for the people and responding to public health events, and build Hainan Haiyao Co.Ltd(000566) into a reliable pharmaceutical enterprise for the army and the people

Industry, and constantly show new achievements in promoting Hainan Haiyao Co.Ltd(000566) to achieve high-quality development!

Hainan Haiyao Co.Ltd(000566) party secretary and Chairman

Wang Jianping

ESG report company profile

Hainan Haiyao Co.Ltd(000566) is a comprehensive pharmaceutical enterprise under Pharmaceutical holding, a wholly-owned secondary subsidiary of Xinxing Jihua Group Corporation Limited(601718) , a central enterprise supervised by the state owned assets supervision and Administration Commission of the State Council. Taking protecting human health as its own responsibility, the company is committed to becoming an influential manufacturer of "generic drugs + innovative drugs" of anti infective drugs in China. The innovation system of the company is complete, the R & D pipeline is competitive, and the core products are well-known in the industry. Historical evolution

The company is listed on the Shenzhen Stock Exchange as a pharmaceutical holding company with Hainan

Listing (Stock Code: Haiyao completion strategy)

Hainan Haiyao Co.Ltd(000566) ), a Chinese group, Hainan Haiyao Co.Ltd(000566) Cheng

The first batch of listed pharmaceuticals of the company's predecessor Haihai company are controlled by central enterprises

Kouchi pharmaceutical factory is a joint-stock manufacturing enterprise, which is also a mixed ownership enterprise in Haikou

Established. Made. The first pharmaceutical industry in southern province has started its development

A listed company. A new journey.

19651992 19942020

Core values

01 R & D

01 take high-end R & D innovation as the core and industrialize R & D achievements in core fields,

Research and development, so as to promote the progress of human health and the sustainable development of the industry

The quality of human life.

02 manufacturing

Guard you and me, take the scientific and technological innovation of the whole industrial chain as the core, and boost the pharmaceutical industry through industrial upgrading

Modernize the health industry within reach, provide high-quality medicine and medical products for health, and improve

Human health level.

03 02 03 business and service

Commercial manufacturing takes the innovation of business model and service model as the core to promote business and service standards

- Advertisment -